Catalyst Wire Dossier Catalyst Wire Dossier

PowderMed HSV-2 DNA Vaccine

DNA vaccine encoding HSV-2 antigen · PowderMed
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PowderMed HSV-2 DNA Vaccine, covering 2008-11-21 to 2008-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects [Phase 1]

See pricing